Vanda Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.05.18	HETLIOZ® (tasimelteon) Effective in Treating Jet Lag during Transatlantic Travel (PR Newswire)
07.05.18	Vanda Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference (PR Newswire)
02.05.18	Vanda Pharmaceuticals Reports First Quarter 2018 Financial Results (PR Newswire)
02.05.18	Alan Bauman, MD, Adds SmartGraft® To Treatment Portfolio, Producing Natural-Looking Hair Transplant Results From His Florida Practice (PR Newswire)
18.04.18	Vanda Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 2, 2018 (PR Newswire)
13.04.18	Vanda Wins Appeal Case on Fanapt® (PR Newswire)
10.04.18	ABBV's SELECT-COMPARE Hits Goals, MNLO's ATOMIK Flops, VTVT Down 63% After-Hrs (RTTNews)
09.04.18	Vanda to Present Tradipitant Scientific Posters at the 10th Georg Rajka International Symposium of Atopic Dermatitis (PR Newswire)
09.04.18	Standard Industries Announces Leadership Changes at BMI Group (PR Newswire)
16.03.18	SELB To Report Gout Data In April, VNDA Down On Share Offering, INNT On Watch (RTTNews)
06.03.18	Vanda Pharmaceuticals Announces Participation at March 2018 Investor Conferences (PR Newswire)
05.03.18	HETLIOZ® (tasimelteon) Demonstrates Efficacy to Treat Jet Lag Disorder in an 8 Hour Phase Advance Clinical Study (PR Newswire)
14.02.18	Vanda Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial Results (PR Newswire)
30.01.18	Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 14, 2018 (PR Newswire)
08.01.18	CELG Makes Blockbuster Purchase, MDXG, NBIX On Watch, Busy Year Ahead For ALNY (RTTNews)
07.01.18	Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2017 Revenue Results and 2018 Guidance (PR Newswire)
02.01.18	KDMN And 10 Other Biotech Stocks You Should Watch This Month (RTTNews)
29.11.17	Eco-Products Helping National Aquarium Turn Trash Into Rich Soil (PR Newswire)
13.11.17	Vanda Pharmaceuticals Announces Participation at November 2017 Investor Conferences (PR Newswire)
13.11.17	FDA Nod For BMY's Sprycel, ARNA To Report Data In Q1, MYL Delists From TASE (RTTNews)
10.11.17	Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatment of Schizophrenia (PR Newswire)
09.11.17	DEPO Building New Specialty Business, FPRX Rebounds, HALO Glows (RTTNews)
07.11.17	Vanda Pharmaceuticals Reports Third Quarter 2017 Financial Results (PR Newswire)
31.10.17	ADMS Draws Attention, AAAP Buyout Rumor Becomes Real, GBT Exudes HOPE (RTTNews)
27.10.17	NEOS Soars On Buyout Bid, INSY Plunges On Founder's Arrest, CELG Bleeds (RTTNews)
24.10.17	Vanda Pharmaceuticals to Announce Third Quarter 2017 Financial Results on November 7, 2017 (PR Newswire)
11.10.17	Vanda Pharmaceuticals Announces Participation at the Oppenheimer Specialty Pharma Summit Conference (PR Newswire)
02.10.17	Vanda to Present Tradipitant Phase II Atopic Dermatitis Data at World Congress of Itch (PR Newswire)
29.09.17	Vanda to Present Scientific Posters at World Sleep 2017 (PR Newswire)
14.09.17	FDA Panel Nod For GSK's Shingles Vaccine, FOLD Beyond Essence, FENC Is Red Hot (RTTNews)
13.09.17	Vanda's Tradipitant Improves Itch and Disease Severity in Patients with Atopic Dermatitis (PR Newswire)
11.09.17	Vanda Pharmaceuticals Announces Participation at September 2017 Investor Conferences (PR Newswire)
06.09.17	Vanda Pharmaceuticals Announces Participation at the Citi 12th Annual Biotech Conference (PR Newswire)
02.08.17	Vanda Pharmaceuticals Reports Second Quarter 2017 Financial Results (PR Newswire)
24.07.17	One Step Closer To EU Approval... (RTTNews)
21.07.17	Vanda Pharma Gets Negative Opinion From European Medicines Agency On Fanaptum (RTTNews)
21.07.17	Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatment of Schizophrenia (PR Newswire)
17.07.17	Vanda Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 2, 2017 (PR Newswire)
12.07.17	Technical Insights on Biotech Stocks -- Curis, OvaScience, Regulus Therapeutics, and Vanda Pharma (PR Newswire)
28.06.17	Santander Holdings USA Announces Capital Distributions and Maintains Capital Strength in Severe Economic Stress Scenario (PR Newswire)
05.06.17	Vanda Pharmaceuticals Announces Participation at June 2017 Investor Conferences (PR Newswire)
30.05.17	Research Reports Initiation on Biotech Stocks -- Corcept Therapeutics, Curis, OvaScience, and Vanda Pharma (PR Newswire)
02.05.17	Vanda Pharmaceuticals Reports First Quarter 2017 Financial Results (PR Newswire)
01.05.17	Vanda Pharmaceuticals to Present at the Deutsche Bank 42nd Annual Health Care Conference (PR Newswire)
13.04.17	Vanda Pharmaceuticals to Announce First Quarter 2017 Financial Results on May 2, 2017 (PR Newswire)
29.03.17	Vanda and UCSF Announce License Agreement for CFTR Activators and Inhibitors (PR Newswire)
07.03.17	How These Biotech Stocks are Faring? -- Corbus Pharma, Advaxis, Vanda Pharma, and Nivalis Therapeutics (PR Newswire)
19.01.17	Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017 (PR Newswire)
10.01.17	Research Reports Coverage on Biotech Stocks -- Cara Therapeutics, Heat Biologics, Vanda Pharma, and Opexa Therapeutics (PR Newswire)
08.12.16	NWBO To Leave Nasdaq, Voyager Cruises Ahead, Watch Out For REGN (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Roche Hldg G	255.50	0.75 %	K V
Nestle	74.88	0.62 %	K V
CieFinRichemont	137.90	0.40 %	K V
Swiss Life Hldg	699.60	0.32 %	K V
Swisscom	504.50	0.30 %	K V
Sika	215.80	-0.37 %	K V
Givaudan	3’966.00	-0.40 %	K V
Lonza Grp	535.80	-0.41 %	K V
Geberit	514.60	-0.46 %	K V
ABB	49.07	-0.95 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Vanda Pharmaceuticals IncShs

Aktien Top/Flop

Vanda Pharmaceuticals Peer Group Nachrichten

Meistgelesene Nachrichten